Mount Yale Investment Advisors’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,115
Closed -$87.1K 792
2025
Q2
$87.1K Buy
+2,115
New +$81.7K 0.01% 688
2024
Q2
Sell
-10,417
Closed -$979K 549
2024
Q1
$979K Buy
10,417
+5,286
+103% +$425K 0.08% 222
2023
Q4
$377K Sell
5,131
-5,142
-50% -$329K 0.04% 372
2023
Q3
$640K Buy
10,273
+1,048
+11% +$70.5K 0.07% 266
2023
Q2
$682K Buy
+9,225
New +$703K 0.07% 266
2018
Q4
Sell
-1,225
Closed -$42K 374
2018
Q3
$42K Sell
1,225
-233
-16% -$7.67K 0.01% 632
2018
Q2
$42K Sell
1,458
-520
-26% -$15.8K 0.01% 662
2018
Q1
$59K Buy
+1,978
New +$64.2K 0.01% 586

Other funds holding BRKR

Mount Yale Investment Advisors's BRKR Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Bruker (BRKR) in Q3 2025, closing a stake of 2,115 shares — an estimated $87.1K sold.

Mount Yale Investment Advisors first reported a position in BRKR in Q1 2018 and held it in 8 quarters. The position peaked at $979K in Q1 2024. 339 funds tracked by Wall St. Rank hold BRKR as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining Bruker position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 2,115 Bruker shares in Q3 2025, an estimated $87.1K.
  • Mount Yale Investment Advisors first reported a position in Bruker in Q1 2018 and held it in 8 quarters.
  • Mount Yale Investment Advisors's Bruker position peaked at $979K in Q1 2024.
  • 339 funds tracked by Wall St. Rank held Bruker as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.